Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Disease Progression and MEN1[original query] |
---|
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability. JCO precision oncology 2019 1 2018 . Raj Nitya, Shah Ronak, Stadler Zsofia, Mukherjee Semanti, Chou Joanne, Untch Brian, Li Janet, Kelly Virginia, Saltz Leonard B, Mandelker Diana, Ladanyi Marc, Berger Michael F, Klimstra David S, Reidy-Lagunes Diane, Osoba Muyin |
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape. BMC medical genomics 2020 11 13 (1): 165. Fojo Tito, Huff Lyn, Litman Thomas, Im Kate, Edgerly Maureen, Del Rivero Jaydira, Pittaluga Stefania, Merino Maria, Bates Susan E, Dean Micha |
- Page last reviewed:Feb 1, 2024
- Content source: